ARCHIVES

Guest Editorial By ACS Chief Medical Officer Otis Brawley: ACS Revises Process for Making Guidelines

This article is from The Cancer Letter archive.

Vol. 38 No. 02 | January 13, 2012

Download PDF Visit The Full Archive

Related Articles

Crout Resigns As Director Of FDA Drugs Bureau

July 11, 1980

Hybridoma Cell Lines Available from NCI

September 3, 1982

In Brief: Senate Confirms Sullivan, Who Fires 100 HHS Political Appointees: Wyngaarden Still On Job

March 10, 1989

In Brief: Roper To Resign From CDC; Clinton Nominates Phillip Lee For Asst. Secretary For Health

March 19, 1993

House Approves Additional Funds For NIH and FDA.

June 20, 2008

FDA To Limit Radiation Doses from Medical Imaging

February 12, 2010